CRSP

CRSP’s latest rating updates from top analysts.

Jaxson Clark

CRISPR Therapeutics AG’s filing revealed that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million on ...

Insider Sale Alert: CRISPR Therapeutics AG [CRSP] – Is it Time to sell?

Anna Perez

CRISPR Therapeutics AG’s recently made public that its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.